RETRACTED ARTICLE: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis – usefulness of alendronate and risedronate-Reference-Cited by-同舟云学术

RETRACTED ARTICLE: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis – usefulness of alendronate and risedronate

Published:2007-10-24 Issue:16 Volume:8 Page:2743-2756
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Iwamoto Jun¹,Takeda Tsuyoshi²,Sato Yoshihiro³

Affiliation:

1. Keio University School of Medicine, Department of Sports Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan ; ;

2. Keio University School of Medicine, Department of Sports Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

3. Department of Neurology, Mitate Hospital, Fukuoka, Japan

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14656566.8.16.2743

Reference97 articles.

1. Osteoporosis Prevention, Diagnosis, and Therapy

2. Molecular mechanisms of action of bisphosphonates

3. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the use of preoperative bisphosphonates in patients with osteopenia and osteoporosis affect lumbar fusion rates? Analysis from a national spine registry;Neurosurgical Focus;2020-08

2. Circular RNA atlas in osteoclast differentiation with and without alendronate treatment;Journal of Orthopaedic Surgery and Research;2020-07-01

3. Effect of bisphosphonate on the prevention of bone loss in patients with gastric cancer after gastrectomy: A randomized controlled trial;Bone;2020-01

4. Quality of prescribing predicts hospitalisation in octogenarians: life and living in advanced age: a cohort study in New Zealand (LiLACS NZ);BMC Geriatrics;2019-12

5. Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease;Medicine;2017-01